1-20 of 95
David Belada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fixed-duration epcoritamab plus R 2 drives favorable outcomes in relapsed or refractory follicular lymphoma

Open Access
Clinical Trials & Observations
Lorenzo Falchi, Anna Sureda, Sirpa Leppä, Joost S. P. Vermaat, Marcel Nijland, Jacob Haaber Christensen, Sven de Vos, Harald Holte, Reid W. Merryman, Pieternella J. Lugtenburg, Pau Abrisqueta, Kim M. Linton, Gauri Sunkersett, Daniela Hoehn, Ali Rana, Aqeel Abbas, Jennifer Marek, Yi Hao, Andrew J. Steele, Christopher Morehouse, Martin Hutchings, David Belada
Journal: Blood
Blood (2025) 146 (22): 2629–2640.
https://doi.org/10.1182/blood.2025029909
Published: 2025
Includes: Supplemental data
Journal Articles

Prognostic impact of diagnosis-to-treatment interval in follicular lymphoma patients treated with immunochemotherapy: Evidence from an international cohort with independent validation

Free
Prokop Vodicka, Tarec Christoffer El-Galaly, Vit Prochazka, Christopher Flowers, Diego Villa, Caroline Dietrich, Herve Ghesquieres, Michael Roost Clausen, Robert Kridel, Chan Cheah, Eliza Hawkes, Björn Wahlin, Maher Gandhi, Melissa Larson, Elliot Cahn, Jonathan Friedberg, Peter Martin, Dai Chihara, Jonathon Cohen, Thomas Habermann, Carla Casulo, Yucai Wang, Peter Brown, Eric Mou, David Belada, Andrea Janikova, Heidi Mocikova, Richard Burack, Izidore S. Lossos, Brad Kahl, Karin Ekstroem Smedby, Laurie Sehn, Marek Trneny, James Cerhan, Matthew Maurer
Journal: Blood
Blood (2025) 146 (Supplement 1): 3601.
https://doi.org/10.1182/blood-2025-3601
Published: 2025
Journal Articles

Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7

Free
Lori Leslie, Gerardo Musuraca, Pau Abrisqueta, Joshua Brody, Jacob Christensen, Alexander Fosså, Marjolein Van Der Poel, Joost Vermaat, Fritz Offner, David Belada, Jian Mei, Isil Altintas, Malene Risum, Aidan Reilly, Liwei Wang, Lorenzo Falchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 465.
https://doi.org/10.1182/blood-2025-465
Published: 2025
Journal Articles

Improved survival with third-line CAR-T therapy vs alternative treatment in DLBCL: A propensity score–matching analysis

Free
Prokop Vodicka, Kamila Polgarova, Frantisek Folber, Juraj Ďuraš, Alice Sykorova, Katerina Steinerova, Heidi Mocikova, Ales Obr, Vit Campr, Katerina Benesova, Andrea Janikova, Michal Kascak, David Belada, Jiri Sramek, Jan Galko, Pavel Klener, Flora Benko, Jitka Dlouha, Petra Blahovcova, Robert Pytlik, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 3664.
https://doi.org/10.1182/blood-2025-3664
Published: 2025
Journal Articles

Pre-treatment circulating tumor DNA predicts survival of diffuse large B-cell lymphoma patients and allows genetic and biological evaluation

Free
Iva Hamova, Prokop Vodicka, Adriana Velasova, Kristyna Kupcova, Petra Zemankova, Petr Nehasil, Anton Tkachenko, Katerina Lochovska, Sarka Muzikova, Jana Senavova, Lucie Dlouha, Magdalena Klanova, Alice Sykorova, Ales Obr, Katerina Benesova, Alexandra Suri, Vit Campr, Jan Galko, Andrea Janikova, David Belada, Vit Prochazka, Pavel Klener, Heidi Mocikova, Marek Trneny, Ondrej Havranek
Journal: Blood
Blood (2025) 146 (Supplement 1): 1763.
https://doi.org/10.1182/blood-2025-1763
Published: 2025
Journal Articles

Bulky disease and/or very high LDH define a high-risk LBCL subgroup within IPI 1–2, but only in younger patients

Free
Prokop Vodicka, David Salek, Katerina Benesova, David Belada, Heidi Mocikova, Veronika Hanackova, Juraj Ďuraš, Katerina Steinerova, Jana Salkova, Zuzana Prouzova, Jan Pirnos, Andrea Janikova, Alice Sykorova, Alexandra Suri, Jan Koren, Jan Galko, Jozef Michalka, Jitka Dlouha, Petra Blahovcova, Vit Campr, Pavel Klener, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 470.
https://doi.org/10.1182/blood-2025-470
Published: 2025
Journal Articles

Validation of novel prognostic models in symptomatic Waldenström's macroglobulinemia based on real-world data

Free
Michal Kascak, Prokop Vodicka, Klara Mensikova, Stork Martin, Zdenek Adam, David Salek, Andrea Janikova, Josef Karban, Jana Salkova, Martin Spacek, David Belada, Alice Sykorova, Martin Simkovic, Pavla Stepankova, Jakub Radocha, Alexandra Jungova, Tereza Dekojova, Pavel Jindra, Katerina Steinerova, Tomas Prochazka, Tomas Jelinek, David Žihala, Juraj Ďuraš, Vit Prochazka, Ales Obr, Veronika Hanackova, Jiri Minarik, Adriana Heindorfer, Jana Klcova, Heidi Mocikova, Jan Soukup, Michal Sykora, Petr Kessler, Radka Schulzova, Marek Wrobel, Lukas Stejskal, Petr Mikula, Vit Campr, Jitka Dlouha, Petra Blahovcova, Ingrid Kovacova, Ludek Pour, Marek Trneny, Roman Hajek
Journal: Blood
Blood (2025) 146 (Supplement 1): 1834.
https://doi.org/10.1182/blood-2025-1834
Published: 2025
Journal Articles

Age-stratified prognostic performance of patient- vs disease-related IPI factors in large B-cell lymphoma

Free
Prokop Vodicka, Matthew Maurer, Pavel Klener, George Cholack, Vit Prochazka, Yucai Wang, David Belada, Christopher Flowers, David Salek, Izidore S. Lossos, Heidi Mocikova, Andrew Feldman, Juraj Ďuraš, Jonathon Cohen, Katerina Steinerova, Carla Casulo, Jan Pirnos, Brad Kahl, Kamila Polgarova, Eric Mou, Andrea Janikova, Peter Martin, Alice Sykorova, Ales Obr, David Jaye, Vit Campr, Diana Malarikova, Shaun Riska, Michal Kascak, Alexandra Suri, Chijioke Nze, Jozef Michalka, Radek Jaksa, Grzegorz Nowakowski, Jitka Dlouha, Petra Blahovcova, Thomas Habermann, Katerina Benesova, James Cerhan, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 4516.
https://doi.org/10.1182/blood-2025-4516
Published: 2025
Journal Articles

Comparable PFS in isolated parenchymal cns vs systemic relapse of DLBCL: Results from a large real-world cohort

Free
Michal Masar, Prokop Vodicka, Samuel Hricko, Alice Sykorova, Andrea Hrušková, Juraj Ďuraš, Alexandra Suri, Veronika Bergerová, Jan Pirnos, Adam Lukac, Katerina Benesova, Martina Filipova, David Belada, Vit Prochazka, Michal Kascak, Heidi Mocikova, Katerina Steinerova, Jan Koren, Andrea Janikova, Pavla Stepankova, Ales Obr, Martina Gerykova, Pavel Klener, David Salek, Jozef Michalka, Jitka Dlouha, Petra Blahovcova, Jan Galko, Vit Campr, Magdalena Klanova, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 3676.
https://doi.org/10.1182/blood-2025-3676
Published: 2025
Journal Articles

FLIPI24 as a prognostic model in marginal zone lymphoma: Results from an international multi-cohort analysis

Free
Prokop Vodicka, Matthew Maurer, Michal Masar, Yucai Wang, Andrea Janikova, Izidore S. Lossos, David Belada, Jonathon Cohen, Ales Obr, Eric Mou, Heidi Mocikova, Carla Casulo, Juraj Ďuraš, Chijioke Nze, Katerina Steinerova, Dilan Patel, Josef Karban, Peter Martin, David Salek, Andrew Feldman, Alice Sykorova, Elliot Cahn, Magdalena Klanova, Vit Campr, David Jaye, Jozef Michalka, Pavla Stepankova, Sergei Syrbu, Samuel Hricko, Alexandra Suri, Melissa Larson, Radek Jaksa, Jitka Dlouha, Thomas Habermann, Petra Blahovcova, Christopher Flowers, Pavel Klener, Vit Prochazka, James Cerhan, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 1826.
https://doi.org/10.1182/blood-2025-1826
Published: 2025
Journal Articles

Epcoritamab + R-mini-CHOP results in 2-year remissions and high MRD negativity rates in elderly patients with newly diagnosed DLBCL: Results from the EPCORE NHL-2 trial

Free
Chan Cheah, Juraj Ďuraš, David Belada, Justin Darrah, Yasmin Karimi, Franck Morschhauser, Gerardo Musuraca, Mats Hellstrom, Katerina Kopeckova, Lori Leslie, Anna Sureda Balarí, Catherine Thieblemont, Umberto Vitolo, Kojo Osei-Bonsu, Yi Hao, Monica Wielgos-Bonvallet, Mina Khoshdeli, Aidan Reilly, Malene Risum, Joost Vermaat, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 64.
https://doi.org/10.1182/blood-2025-64
Published: 2025
Journal Articles

Fixed-duration epcoritamab monotherapy induces high response and MRD-negativity rates in elderly patients with newly diagnosed large B-cell lymphoma (LBCL) and comorbidities: Results from EPCORE DLBCL-3

Free
Umberto Vitolo, Johannes Duell, Juan Miguel Bergua Burgues, Wojciech Jurczak, Michal Kwiatek, Marie Maerevoet, Sergio Ortegon Alcaide, David Belada, Won Seog Kim, Richard Greil, Raul Cordoba, Juan-Manuel Sancho, David Sibon, Catherine Thieblemont, Takahiro Kumode, Monica Wielgos-Bonvallet, Tony Jiang, Yanli Wang, Stephanie McGoldrick, Evelyn Guo, Franck Morschhauser, Sherida Woei-A-Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 63.
https://doi.org/10.1182/blood-2025-63
Published: 2025
Journal Articles

Longitudinal immune monitoring in patients treated with CD19 and BCMA CAR-T cells using standardized 8‑color flow cytometry panel reveals substantial differences among products kinetics and persistence

Free
Ondrej Venglar, Viera Hrabcakova, Ondrej Soucek, Kamila Kutejova, David Žihala, Jana Mihalyova, Michaela Hornakova, Tereza Sevcikova, Lucie Broskevicova, Lenka Janska Vojtkova, Marek Borsky, Jakub Radocha, Pavel Zak, Michael Doubek, Tomas Kalina, Roman Hajek, David Belada, Frantisek Folber, Tomas Jelinek
Journal: Blood
Blood (2025) 146 (Supplement 1): 5721.
https://doi.org/10.1182/blood-2025-5721
Published: 2025
Journal Articles

Fixed-duration epcoritamab + R-CHOP in patients with newly diagnosed DLBCL and high IPI scores (3–5) led to sustained remissions and disease-free survival beyond 3 years: Results from the EPCORE NHL-2 trial

Free
Lorenzo Falchi, Fritz Offner, Sven de Vos, Joshua Brody, Daniel Morillo, Kim Linton, Sylvia Snauwaert, Michael Roost Clausen, Raul Cordoba, Toshihiko Oki, Monica Wielgos-Bonvallet, Mina Khoshdeli, Yi Hao, Jennifer Marek, Malene Risum, David Belada
Journal: Blood
Blood (2025) 146 (Supplement 1): 1955.
https://doi.org/10.1182/blood-2025-1955
Published: 2025
Journal Articles

Epcoritamab + GemOx achieves durable >2-year remissions in relapsed/refractory (R/R) 2L+ diffuse large B-cell lymphoma (DLBCL): Long-term data reinforce clinical potential of the regimen across a diverse patient population

Free
Joshua Brody, David Belada, Daniel Morillo, Régis Costello, Marek Trneny, Sven de Vos, Gerardo Musuraca, Umberto Vitolo, David Lewis, Jacob Christensen, Marcel Nijland, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Jennifer Marek, Liwei Wang, Malene Risum, Raul Cordoba, Judit Jørgensen
Journal: Blood
Blood (2025) 146 (Supplement 1): 3736.
https://doi.org/10.1182/blood-2025-3736
Published: 2025
Journal Articles

Outcomes of T-cell/histocyte-rich large B-cell lymphoma (THRLBCL): An international LEO/MER and NiHiL collaborative study

Free
Juan Alderuccio, Prokop Vodička, Jean Koff, Andrea Janikova, Matthew Maurer, Katerina Benesova, Heidi Mocikova, Peter Martin, Katerina Steinerova, Dilan Patel, David Belada, James Cerhan, Juraj Ďuraš, Vit Prochazka, Jonathon Cohen, David Salek, Thomas Habermann, Jan Koren, Melissa Larson, Andrew Feldman, Alexandra Suri, Patrick Reagan, Alice Sykorova, Jozef Michalka, Diana Malarikova, Yucai Wang, David Jaye, Zuzana Prouzova, Petra Blahovcova, Vit Campr, Eric Mou, Christopher Flowers, Izidore S. Lossos, Jonathan Friedberg, Grzegorz Nowakowski, Dai Chihara, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 898.
https://doi.org/10.1182/blood-2025-898
Published: 2025
Journal Articles

Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts

Free
Prokop Vodicka, Yucai Wang, Katerina Benesova, Patrick Reagan, David Salek, Izidore S. Lossos, Vit Prochazka, Jean Koff, Alice Sykorova, Eric Mou, Heidi Mocikova, Andrew Feldman, Zuzana Prouzova, Brad Kahl, Juraj Ďuraš, Mazie Tsang, Katerina Steinerova, Chijioke Nze, Diana Malarikova, Raphael Mwangi, Andrea Janikova, Arushi Khurana, Jan Galko, Peter Martin, Kamila Polgarova, Sergei Syrbu, Jan Koren, Ales Obr, Jonathan Friedberg, David Belada, Michal Kascak, Jonathon Cohen, Michal Masar, Alexandra Suri, Grzegorz Nowakowski, Samuel Hricko, Andrea Hrušková, Christopher Flowers, Veronika Bergerova, Petra Blahovcova, Matthew Maurer, Jozef Michalka, Vit Campr, Thomas Habermann, Pavel Klener, James Cerhan, Marek Trneny
Journal: Blood
Blood (2025) 146 (Supplement 1): 786.
https://doi.org/10.1182/blood-2025-786
Published: 2025
Journal Articles

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Open Access
Clinical Trials & Observations
Joshua D. Brody, Judit Jørgensen, David Belada, Régis Costello, Marek Trněný, Umberto Vitolo, David John Lewis, Yasmin H. Karimi, Anna Sureda, Marc André, Björn E. Wahlin, Pieternella J. Lugtenburg, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Aqeel Abbas, Liwei Wang, Malene Risum, Raul Cordoba
Journal: Blood
Blood (2025) 145 (15): 1621–1631.
https://doi.org/10.1182/blood.2024026830
Published: 2025
Includes: Supplemental data
Journal Articles

Fixed-Duration Epcoritamab + R-CHOP Induces High Complete Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Withhigh-Risk Features: Long-Term Results from the Epcore NHL-2 Trial

Free
Lorenzo Falchi, Fritz Offner, Sven de Vos, Joshua Brody, Raul Cordoba, Kim Linton, Sylvia Snauwaert, Michael Roost Clausen, Toshihiko Oki, Andrew J. Steele, Yi Hao, Kimberly G. Archer, Ali Rana, David Belada
Journal: Blood
Blood (2024) 144 (Supplement 1): 581.
https://doi.org/10.1182/blood-2024-198023
Published: 2024
Journal Articles

Fixed-Duration Epcoritamab + R 2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial

Free
Lorenzo Falchi, Anna Sureda Balari, Sirpa Leppä, Joost S.P. Vermaat, Marcel Nijland, Jacob Haaber Christensen, Sven de Vos, Harald Holte, Reid W. Merryman, Pieternella Lugtenburg, Pau Abrisqueta Costa, Kim Linton, Gauri Sunkersett, Christopher Morehouse, Andrew J. Steele, Jennifer Marek, Liwei Wang, Daniela Hoehn, Martin Hutchings, David Belada
Journal: Blood
Blood (2024) 144 (Supplement 1): 342.
https://doi.org/10.1182/blood-2024-200262
Published: 2024